4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001219036-21-000002
Chief Scientific Officer sold 80,000 shares at $29.71 ($2,377,048)
- Chief Scientific Officer acquired 80,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LANCHBURY JERRY S Chief Scientific Officer | 2021-02-16 | Option exercise | +74,445 | $18.00 | $1,340,010 | 321,020 | D: show line 1 in the form |
| LANCHBURY JERRY S Chief Scientific Officer | 2021-02-16 | Sale | −74,445 | $29.71 | $2,211,992 | 246,575 | D: show line 2 in the form |
| LANCHBURY JERRY S Chief Scientific Officer | 2021-02-16 | Option exercise | +5,555 | $18.00 | $99,990 | 252,130 | D: show line 3 in the form |
| LANCHBURY JERRY S Chief Scientific Officer | 2021-02-16 | Sale | −5,555 | $29.71 | $165,056 | 246,575 | D: show line 4 in the form |
| Open-market sales · 80,000 sh · avg $29.71 · $2,377,048 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LANCHBURY JERRY S Chief Scientific Officer | 2021-02-16 | Option exercise · Incentive Stock Option (right to buy) | −5,555 | 0 | D: show line 5 in the form | ||
| LANCHBURY JERRY S Chief Scientific Officer | 2021-02-16 | Option exercise · Non-Qualified Stock Option (right to buy) | −74,445 | 0 | D: show line 6 in the form |
Loading xslF345X03/edgardoc.xml…